Archives by: Dr.med. Napoleon DeLeon

Dr.med. Napoleon DeLeon

44 Posts 0 comments

About the author

Dr.med. Napoleon DeLeon holds a degree in medicine from the United Arab Emirates College, Al Ain, UAE. With over 15 years of experience, he is an expert in evaluating and curating healthcare web content based on clinical evidence.

Dr.med. Napoleon DeLeon Posts

Our Technology

Our Technology
Our NanoSphere Delivery System™ (NDS) solves for a great deal of the safety, stability, absorption, bioavailability, dosing, timing of onset and duration challenges that seriously hinder industries delivering ...
Read more 0

NanoSphere Signs Definitive Licensing Agreement with Delta 9 Cannabis Inc.

NanoSphere Signs Definitive Licensing Agreement with Delta 9 Cannabis Inc.
Vancouver, BC  – NanoSphere Health Sciences Inc. (CSE: NSHS) (OTC: NSHSF) is pleased to announce the Company has signed a Definitive Master Licensing Agreement (the Agreement) with Delta ...
Read more 0

Technology

Technology
We pride ourselves on having one of the most advanced research and development programs in the industry. The Science behind our Technology We have the most advanced drug ...
Read more 0

Our Team

Our Team
Officers Dr. Mark Percival, Chief Executive Officer Stephanie Hopper, Chief Operations Officer, Director Richard Clark Kaufman Ph.D., Chief Science Officer, Director Terry Grossman M.D., Chief Medical Officer Bennett ...
Read more 0

NanoSphere Developing Production Lab at Delta 9 Cannabis

NanoSphere Developing Production Lab at Delta 9 Cannabis
– NanoSphere’s First Canadian Products Scheduled for Initial Production in April – NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICES VANCOUVER – ...
Read more 0

NanoSphere Health Sciences Inc. Is Nominated For NCIA’s Excellence In Technology Award And Recieves OTC Trading Symbol

NanoSphere Health Sciences Inc. Is Nominated For NCIA’s Excellence In Technology Award And Recieves OTC Trading Symbol
DENVER, Jan. 11, 2018 /PRNewswire/ — NanoSphere Health Sciences Inc. (CSE: NSHS, “NanoSphere”) is pleased to announce that it has been nominated for the National Cannabis Industry Association’s Excellence ...
Read more 0

Patent Portfolio

Patent Portfolio
NanoSphere Health Sciences works systematically with its intellectual property (IP) development team to achieve a strategic and strong patent position in the nanotechnology market. We continue to protect ...
Read more 0

Cannabis

Cannabis
NanoSphere’s proprietary transdermal products sold under our in-house brand – Evolve Formulas, are revolutionizing how cannabis delivers its benefits. Sold as NanoSerum™, our transdermal products enable the active ...
Read more 0

NanoSphere Health Sciences Awarded Breakthrough Patent for Disruptive Nanoparticle Delivery Platform

NanoSphere Health Sciences Awarded Breakthrough Patent for Disruptive Nanoparticle Delivery Platform
LANDMARK PATENT MARKS MOST SIGNIFICANT ADVANCEMENT IN OVER 25 YEARS FOR NON-INVASIVE MEDICAL DELIVERY SYSTEM Denver – NanoSphere Health Sciences Inc (CSE: NSHS) (OTC: NSHSF) is pleased to announce ...
Read more 0

NanoSphere Health Sciences Inc. Signs License Agreement to Open California Market

NanoSphere Health Sciences Inc. Signs License Agreement to Open California Market
DENVER – January 18, 2018 – NanoSphere Health Sciences Inc. (CSE: NSHS, “NanoSphere”) is pleased to announce that it has signed an agreement to license its technology, as ...
Read more 0